Health ❯ Healthcare ❯ Cardiovascular Health

Risk Reduction

Heart Attack Prevention Medications Obesity and Heart Disease

FDA Clears Wegovy Tablet, First Oral GLP‑1 for Weight Management

Novo Nordisk targets an early‑January U.S. rollout with a $149 starter offer.